Where will Calquence combo be standard care for first-line MCL by end of 2025? | Categorical | | | 23 hours ago | |
Will EMA approve AstraZeneca's Calquence combination for first-line MCL by end of 2025? | Binary | | | 23 hours ago | |
Will NCCN include Calquence combination in guidelines for first-line MCL by mid-2025? | Binary | | | 23 hours ago | |
Will Calquence combination show significant overall survival improvement in trials by end of 2025? | Binary | | | 23 hours ago | |
What market share will Calquence combo achieve in U.S. for first-line MCL by end of 2025? | Categorical | | | 23 hours ago | |
What percentage of serious adverse events will be reported for Calquence combo by Jan 2026? | Categorical | | | 23 hours ago | |
Medicare to negotiate over 50% price reduction for Ozempic by 2026? | Binary | | | 1 day ago | |
Novo Nordisk to challenge Medicare price negotiation in court by 2025? | Binary | | | 1 day ago | |
Supply disruption for any of the 15 negotiated drugs by 2026? | Binary | | | 1 day ago | |
Drug with highest percentage price reduction in Medicare negotiation by 2026? | Categorical | | | 1 day ago | |
Pharmaceutical company saving most from Medicare negotiation by 2026? | Categorical | | | 1 day ago | |
Drug facing most significant public backlash due to Medicare price negotiations by 2025? | Categorical | | | 1 day ago | |
